Solid Biosciences (SLDB) PT Raised to $18 at Piper Sandler
Tweet
Share
E-mailGet Alerts SLDB Hot Sheet
Price: $9.30 +2.20%
Rating Summary:
16 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
16 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Piper Sandler analyst Biren Amin raised the price target on Solid Biosciences (NASDAQ: SLDB) to $18.00 (from $17.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Truist Securities Assumes Solid Biosciences (SLDB) at Buy
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
- Beike (BEKE) PT Raised to $23 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
